Search clinical trials for: H2 15O PET/CT

Total 1527 results

Dallas VA Medical Center

Terminated

Defining the Utility of PET/CT in the Follow-up of Patients With Solid Tumors

Solid Tumors | Cancer Recurrence

United States
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor

Malignancy

China
University Hospital, Bordeaux

Completed

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks (UROPET)

Prostate Cancer

France
Affiliated Cancer Hospital & Institute of Guangzhou...

Not yet recruiting

18F-FAPI and 18F-FDG PET/CT in Patients With Various Types of Cancer (FAPI-VTC)

Cancer
Celal Bayar University

Completed

The Role of 68GA DOTATATE PET/CT In Breast Cancer Imaging

Breast Cancer

Turkey
University Medical Center Groningen

Completed

AR and ER Imaging in Metastatic Breast Cancer

Metastatic Breast Cancer

Netherlands
Stanford University

Recruiting

Pediatric PET/MR Image Registry

Lymphoma | Osteosarcoma | Soft Tissue

United States
Memorial Sloan Kettering Cancer Center

Recruiting

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

Colorectal Cancer | Colon Cancer | Liver Metastasis Colon Cancer | Adenocarcinoma of the Rectum | Colon Cancer Liver Metastasis | Adenocarcinoma of the Colon

United States
First Affiliated Hospital of Fujian Medical University

Recruiting

[68Ga]Ga-P15-041 PET/CT in Variety of Bone Tumors

Bone Metastases | Bone Tumor

China
GE Healthcare
PPD; Fortrea

Not yet recruiting

A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy Volunteers

Healthy Volunteers

United States
Puerta de Hierro University Hospital
Gilead Sciences

Recruiting

Usefulness of PET-CT for Invasive Fungal Infection (PETIFI)

Invasive Fungal Infections

Spain
Ontario Clinical Oncology Group (OCOG)
Cancer Care Ontario

Completed

Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer (PET ABC)

Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4) | Stage IIb Breast Cancer (T3N0)

Canada
Abramson Cancer Center of the University of Pennsylvania

Terminated

Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast Cancer

METASTATIC BREAST CANCER

United States
University of Aarhus
The Danish Medical Research Council

Withdrawn

The Utility of PET/CT in the Planning of Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer

Non-small Cell Lung Cancer
Institute of Cancer Research, United Kingdom
Royal Marsden NHS Foundation Trust; National Institute for Health Research,...

Completed

Imaging NSCLC Treatment Response to Immunotherapy

Cancer

United Kingdom
Regina Elena Cancer Institute

Completed

Evaluating the Role of Both PSMA and 64Cu-PET/CT Total Body in Patients With Locally Relapsed Prostate Cancer

Prostate Neoplasms

Italy
AHS Cancer Control Alberta
Calgary Health Region

Unknown

The Utility of FDG-PET for Radiation Treatment in NSCLC

Lung Neoplasms | Positron Emission Tomography

Canada
National Cancer Institute (NCI)

Terminated

Imaging Studies of Kidney Cancer Using 18F-VM4-037

Kidney Neoplasms | Carcinoma, Renal Cell

United States
Université de Sherbrooke

Unknown

Early Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CT

Lymphoma, Large-Cell

Canada
British Columbia Cancer Agency

Withdrawn

FDGal PET/CT to Detect Hepatocellular Carcinoma

Liver Cirrhosis | Hepatocellular Carcinoma | Chronic Liver Disease

Canada
UMC Utrecht

Recruiting

68Ga PET/CT Versus 99mTc SPECT/CT for Lung Perfusion and Ventilation Scintigraphy; a Technical and Practical Feasibility Study (GaTcha)

Pulmonary Embolism | Ventilation Perfusion Mismatch

Netherlands
British Columbia Cancer Agency

Not yet recruiting

Preliminary Assessment of [18F]BL40 in PET/CT Scans

Multiple Myeloma | Waldenström Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma

Canada
Boston Children's Hospital
National Institutes of Health (NIH)

Enrolling by invitation

Pain in Fibrous Dysplasia

Fibrous Dysplasia/McCune-Albright Syndrome

United States
Jinling Hospital, China

Not yet recruiting

To Compare the Clinical Application of 18F-LNC1007 Injection PET/CT and 18F-FDG PET/CT (18F-LNC1007)

Tumour
GlaxoSmithKline
Quintiles, Inc.

Completed

A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts

Autoimmune Diseases

United Kingdom
University Hospital, Antwerp
Universiteit Antwerpen

Recruiting

A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)

Neuroendocrine Tumors

Belgium, Cyprus
Huashan Hospital

Recruiting

A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors

Kidney Cancer | Positron Emission Tomography | Lymphomas

China
Institut Cancerologie de l'Ouest

Active, not recruiting

Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer (TEP-FES)

Metastatic Breast Cancer

France
University Hospital, Ghent
XEOS Medical

Completed

Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT

Head and Neck Neoplasms | Thyroid Neoplasm | Skin Neoplasm

Belgium
Rambam Health Care Campus

Completed

The Benefit of FDG PET CT in the Treatment Algorithm of Staphylococcus Aureus Bacteremia (PETCT4SAB)

Staphylococcus Aureus Bacteremia

Israel
Jonsson Comprehensive Cancer Center
ImaginAb, Inc.

Completed

Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer

Pancreatic Cancer | Prostate Cancer | Bladder Cancer

United States
M.D. Anderson Cancer Center

Withdrawn

Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma

Lymphoma | Mantle Cell Lymphoma
Radboud University Medical Center

Unknown

Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.

Head and Neck Cancer

Netherlands
Rigshospitalet, Denmark

Withdrawn

New Indications for Ultrasound in the Staging of Cervical Cancer

Cervical Cancer

Denmark
Miami Cancer Research Center, Inc.

Recruiting

I-124 PET/CT Imaging and Dosimetry for RAI-Naïve or Refractory Thyroid Cancer

Thyroid Cancer | RAI-Refractory Thyroid Cancer

United States
ABSCINT NV/SA

Not yet recruiting

HER2 Targeted Molecular Imaging in mBC Using 68Ga-ABS011 (HERMIA)

Metastatic Breast Cancer

Belgium
University of Texas Southwestern Medical Center
RefleXion Medical

Not yet recruiting

Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1

Prostate Cancer
Semmelweis University Heart and Vascular Center
Semmelweis University Department of Pulmonology; Semmelweis University Medical...

Recruiting

COvid iMaging With POSitron Emission Tomography (COMPOSIT)

Coronavirus Infection

Hungary
Central Hospital, Nancy, France

Recruiting

Contribution of Cerebral 18F-DOPA PET-CT Scan in High-grade Recurrent Gliomas (DORA)

High Grade Glioma

France
Abramson Cancer Center of the University of Pennsylvania

Terminated

Early FDG PET in Melanoma

Clinical Stage III Nodal or Intransit Disease or Resectable Stage IV Melanoma

United States
University Hospital, Toulouse

Completed

Secretory Azoospermia and FDG (Fluoro Deoxyglucose) PET-CT (AzoPredHisto)

Fertility

France
University of California, Davis

Completed

A Feasibility Study to Determine PET/CT Imaging of Blood Flow to the Bone (PETCT)

Normal Subjects

United States
Odense University Hospital

Completed

Evaluation of Preoperative Investigations in Patients With Liver Cancer

Primary Liver Cancer | Liver Metastasis

Denmark
The Christie NHS Foundation Trust

Recruiting

Introduction of Y90-PET-CT Post Radioembolisation Therapy Scans (Y90-PET-CT)

Cancer

United Kingdom
Medhat Osman
Blue Earth Diagnostics

Completed

Prostate Cancer Patients With Biochemical Recurrence

Patients With Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Imaging With a New Agent That Finds a Cancer Protein Called HER2

HER2-positive Carcinoma | HER2-positive Primary Malignancy

United States
Universiteit Antwerpen
University Hospital, Antwerp; Kom Op Tegen Kanker

Completed

A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET)

Neuroendocrine Tumors

Belgium
Merck Sharp & Dohme LLC

Terminated

A Study to Evaluate [18F]-FDG PET (Fluorodeoxyglucose-positron) in Patients With Pancreatic Cancer (MK-0000-144)

Advanced Pancreatic Adenocarcinoma
Sun Yat-sen University

Completed

Total-body PET/CT Imaging Using the uEXPLORER in Non-small Cell Lung Cancer Patients Treated by Induction Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiotherapy

Non-small Cell Lung Cancer

China
Imperial College London
Biogen; Invicro

Completed

TSPO PET as a Measure of Post-stroke Brain Inflammation: a Natural History Cohort

Inflammatory Response | Stroke, Ischemic | Stroke, Acute

United Kingdom

Search clinical trials for: H2 15O PET/CT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations